Our entrepreneurial culture provides each employee the ability to act in a meaningful and independent manner to improve the health of Canadians. Teams are the core of the two business divisions, rare disease and multiple sclerosis.
Since our establishment in 1996, Genzyme Canada continues to grow year over year. With this growth has come the need to increase the size and complexity of our Operation.
Genzyme Canada now has representatives concentrating on key healthcare institutions throughout Canada. These men and women are the primary interface with healthcare professionals and provide the innovative products and services that Genzyme offers in Canada.
The future of healthcare will change with the development of new products and services. Genzyme Canada is committed to involving Canadian researchers, bench-top and clinical, and institutions in our R&D (research & development) of our current and future products and services.
Our commitment is to positively impact on the health of Canadians. Genzyme Canada will continue to strive in meeting the significant unmet medical needs of Canadians.